Global UAV signs LOI to acquire Nexus Peptide Sciences, plans $3 million-$5 million equity raise

Reuters2026/07/27 14:23

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Global UAV Technologies entered a July 27, 2026 LOI to acquire Vancouver-based biotech Nexus Peptide Sciences.
Consideration includes 20,300,000 common shares, 7,000,000 transferable warrants exercisable at $0.10, plus a $100,000 cash finder’s fee.
Each warrant converts into one share at $0.10 for two years following closing.
The buyer targets an equity financing of $3 million to $5 million on or before closing.
Parties aim to sign a definitive agreement by Aug. 31, 2026; Nexus would become a wholly owned subsidiary at closing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Global UAV Technologies Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202607271022NEWSFILECNPR____20260727_306632_1) on July 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Global UAV signs LOI to acquire Nexus Peptide Sciences, plans $3 million-$5 million equity raise

You may also like

Crypto prices